A major advance in cancer study is arising with the use of mini-antibodies to re-engage mutated p53. This vital malignant suppressor protein is frequently inactivated in many types of cancer, leading uncontrolled cell https://mysterybookmarks.com/story21884960/mini-antibodies-revive-the-p53-protein-new-promising-pathway-for-cancer-management